The development of crystal habit control methods involves managing how external crystallization conditions affect the preferential growth or inhibition of different crystal faces. This influences the uniform distribution of molecules across crystals, resulting in varied external shapes, known as crystal habits. Different crystal habits exhibit varying flow characteristics and dissolution rates. For instance, with lopinavir, different crystallization conditions can produce plate-like or needle-like crystal habits. Needle-like crystals tend to dissolve faster but have poorer flow properties.
The crystal habit of a drug significantly impacts its stability, especially in formulations like suspensions. For example, suspensions containing symmetric cylindrical calcium carbonate particles are more stable upon settling compared to those with asymmetric needle-shaped particles, which are prone to forming cake-like aggregates.
During the crystallization process, additives can be introduced to either promote or inhibit crystal growth. Small amounts of additives can also alter crystal habit by interacting with specific crystal faces. Additionally, crystal habit can be controlled by adjusting crystal growth conditions such as solvent choice, temperature, degree of supersaturation, cooling rate, and stirring speed.
Effective control of crystal habit is crucial in pharmaceutical development to ensure stable product performance and quality.